‘Potentially Driver Impairing’ (PDI) Medication Use in Medically Impaired Adults Referred for Driving Evaluation

Por Hetland, Amanda J., Carr, David B., Wallendorf, Michael J., Barco, Peggy P.
Publicado em 2014

Predicting Road Test Performance in Drivers with Dementia

Por Carr, David B., Barco, Peggy P., Wallendorf, Michael J., Snellgrove, Carol A., Ott, Brian R.
Publicado em 2011

Predicting Road Test Performance in Drivers With Stroke

Por Barco, Peggy P., Wallendorf, Michael J., Snellgrove, Carol A., Ott, Brian R., Carr, David B.
Publicado em 2014

Fentanyl and Midazolam are Ineffective in Reducing Episodic Intracranial Hypertension in Severe Pediatric Traumatic Brain Injury

Por Welch, Timothy P., Wallendorf, Michael J., Kharasch, Evan D., Leonard, Jeffrey R., Doctor, Allan, Pineda, Jose A.
Publicado no Crit Care Med (2016)

Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery

Por Sterl, Karin, Wang, Songyan, Oestricker, Lauren, Wallendorf, Michael J, Patterson, Bruce W., Reeds, Dominic N., Wice, Burton M
Publicado no Peptides (2016)

A Novel Low-Energy Electrotherapy That Terminates Ventricular Tachycardia With Lower Energy than a Biphasic Shock When Anti-Tachycardia Pacing Fails

Por Janardhan, Ajit H., Li, Wenwen, Fedorov, Vadim V., Yeung, Michael, Wallendorf, Michael J., Schuessler, Richard B., Efimov, Igor R.
Publicado no J Am Coll Cardiol (2012)

Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus

Por Chowdhury, Sara, Wang, Songyan, Dunai, Judit, Kilpatrick, Rachel, Oestricker, Lauren Z., Wallendorf, Michael J., Patterson, Bruce W., Reeds, Dominic N., Wice, Burton M.
Publicado no PLoS One (2016)

Global Biochemical Profiling Identifies β-Hydroxypyruvate as a Potential Mediator of Type 2 Diabetes in Mice and Humans

Por Zhang, Sheng, Wang, Songyan, Puhl, Matthew D., Jiang, Xuntian, Hyrc, Krzysztof L., Laciny, Erin, Wallendorf, Michael J., Pappan, Kirk L., Coyle, Joseph T., Wice, Burton M.
Publicado no Diabetes (2015)

Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes

Por Wice, Burton M., Reeds, Dominic N., Tran, Hung D., Crimmins, Dan L., Patterson, Bruce W., Dunai, Judit, Wallendorf, Michael J., Ladenson, Jack H., Villareal, Dennis T., Polonsky, Kenneth S.
Publicado em 2012

Lumbar Cerebrospinal Fluid Biomarkers of Posthemorrhagic Hydrocephalus of Prematurity: Amyloid Precursor Protein, Soluble Amyloid Precursor Protein α, and L1 Cell Adhesion Molecule...

Por Morales, Diego M., Silver, Shawgi A., Morgan, Clinton D., Mercer, Deanna, Inder, Terri E., Holtzman, David M., Wallendorf, Michael J., Rao, Rakesh, McAllister, James P., Limbrick, David D.
Publicado no Neurosurgery (2017)

Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus

Por Limbrick, David D., Baksh, Brandon, Morgan, Clinton D., Habiyaremye, Gakwaya, McAllister, James P., Inder, Terrie E., Mercer, Deanna, Holtzman, David M., Strahle, Jennifer, Wallendorf, Michael J., Morales, Diego M.
Publicado no PLoS One (2017)

Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without Type 2 diabetes

Por Chowdhury, Sara, Reeds, Dominic N., Crimmins, Dan L., Patterson, Bruce W., Laciny, Erin, Wang, Songyan, Tran, Hung D., Griest, Terry A., Rometo, David A., Dunai, Judit, Wallendorf, Michael J., Ladenson, Jack H., Polonsky, Kenneth S., Wice, Burton M.
Publicado em 2013